US Patent 12,653,779 — assignment history and current owner

US 12,653,779 · Application 18/239,045

Compositions And Methods For The Treatment Of Presbyopia

Who owns US Patent 12,653,779?

US12653779 ("Compositions And Methods For The Treatment Of Presbyopia") — current assignee: LENZ THERAPEUTICS OPERATIONS, INC.. Status: Active, estimated expiration March 24, 2034. 2 recorded USPTO assignments.

Based on recorded USPTO assignment data, the apparent operating assignee of US Patent 12,653,779 is LENZ THERAPEUTICS OPERATIONS, INC.. Based on the most recent name change record (recorded 2024-04-02).

Patent title
Compositions And Methods For The Treatment Of Presbyopia
Application number
18/239,045
Apparent operating assignee
LENZ THERAPEUTICS OPERATIONS, INC.
Patent status
Active, estimated expiration March 24, 2034
Recorded assignments
2

Recorded assignment history

ExecutedRecordedConveyanceAssignor(s)Assignee(s)Reel/frame
Dec 3, 2023Dec 13, 2023Ownership TransferHORN, GERALDLENZ THERAPEUTICS, INC.65857/144
Mar 21, 2024Apr 2, 2024Name ChangeLENZ THERAPEUTICS, INC.LENZ THERAPEUTICS OPERATIONS, INC.66978/82

Scrolls sideways on narrow screens

Chain of title

In 2023, HORN, GERALD assigned the patent to LENZ THERAPEUTICS, INC.. In 2024, LENZ THERAPEUTICS, INC. changed its name to LENZ THERAPEUTICS OPERATIONS, INC..

Apparent recorded rights summary — disclaimer

This tool presents recorded assignment data from the USPTO assignment database. It does not constitute a legal opinion on ownership or title. Assignments may exist that have not been recorded. Corrective records, off-record transfers, court orders, and other events may affect actual ownership. Consult a qualified patent attorney for definitive title analysis.

Ownership settled? Give your AI the file.

Application 18/239,045 · US 12,653,779

The recorded chain of title is one part of the record. PatentReply compiles the rest of US 12,653,779, from the claims as filed to the last action, for Claude, ChatGPT, Grok, or another supported AI client.

One new published application a month is free. The first compile takes a few minutes.

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Data sourced from public USPTO assignment records. This tool provides informational summaries and should not be relied upon as legal advice or a definitive title opinion. Always verify patent ownership independently, especially where unrecorded transfers, court orders, or other off-record events may apply.